Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)

NCT00903721 · clinicaltrials.gov ↗

COMPLETED

Status

3806

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis

Interventions

DRUG: mometasone furoate

Sponsor

Organon and Co